FEN1 and lung carcinoma: PRMT1 knockdown decreases FEN1 expression and increases DNA damage in A549 lung cancer cells treated with Temozolomide (TMZ) or 5-fluoro-uracil, which can be partially rescued by overexpressing FEN1 [95].